Eurasian Journal of Critical Care

Eurasian Journal of Critical Care

THE NEW BIOMARKERS USED IN THE DIFFERENTIATION BETWEEN TRANSUDATE AND EXUDATE PLEURAL EFFUSIONS

Yazarlar: Turgut TEKE, Kerim YESİLDAG

Cilt 1 , Sayı 3 , 2019 , Sayfalar 105 - 110

Konular:Yoğun Bakım, Tıp

Anahtar Kelimeler:Pleural effusion,New biomarkers

Özet: Etiological diagnosis of pleural effusion is sometimes easy and sometimes very difficult challenge. In most of patients with pleural effusion, the symptoms, signs and laboratory data are not pathognomonic for etiologic diagnosis.  In a patient with an undiagnosed pleural effusion, the first question to answer is whether the fluid is a transudate or an exudate. This is usually determined by means of Light's criteria. In patients under diuretic treatment, Light's criteria misclassify transudates as exudates, but the pleural fluid NT-pro-BNP levels usually is above 1500 pg/mL in pleural effusions associated with heart failure.

ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır
KAYNAK GÖSTER
BibTex
KOPYALA
@article{2019, title={THE NEW BIOMARKERS USED IN THE DIFFERENTIATION BETWEEN TRANSUDATE AND EXUDATE PLEURAL EFFUSIONS}, volume={1}, number={3}, publisher={Eurasian Journal of Critical Care}, author={Turgut TEKE,Kerim YESİLDAG}, year={2019}, pages={105–110} }
APA
KOPYALA
Turgut TEKE,Kerim YESİLDAG. (2019). THE NEW BIOMARKERS USED IN THE DIFFERENTIATION BETWEEN TRANSUDATE AND EXUDATE PLEURAL EFFUSIONS (Vol. 1, pp. 105–110). Vol. 1, pp. 105–110. Eurasian Journal of Critical Care.
MLA
KOPYALA
Turgut TEKE,Kerim YESİLDAG. THE NEW BIOMARKERS USED IN THE DIFFERENTIATION BETWEEN TRANSUDATE AND EXUDATE PLEURAL EFFUSIONS. no. 3, Eurasian Journal of Critical Care, 2019, pp. 105–10.
Atıf Görüntüle
PDF Görüntüle
Kaynak Görüntüle
Paylaş
Dergi Bilgileri